top of page

GW-501516

GW- 501516 is a peroxisome
proliferator-activated receptor
(PPAR) that it totally destroyed
fat cells while enhancing muscle
cell growth, increased metabolism
and its the ultimate workout enhancer.

CARDARINE

Read More
LGD-4033 is a novel nonsteroidal, oral Selective Androgen Receptor Modulator that binds to the androgen receptor with high affinity and selectivity. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. This compound has a slightly stronger physiological effect on test subjects than its counterpart MK-2866 (Osterine). Approximately 3% of test Subjects are Non-Responsive to LGD-4033. This compound has displayed a significant improvement in the general physiology of test subjects, including a marked increase in Lean muscle mass (improving the test subjects Body Mass Index). Physiological improvements of test subjects are considered dry with just slight water retention and a substantial improvement in the quality and density of muscle fiber tissue. The Pro version of LGD-4033 contains an "Absorb Core" base to improve bioavailability and to extend the half-life of the compound, making it one of the strongest and most efficient on the Research Compound market. LGD-4033 is slightly suppressive so a light PCT is required following administration of a course of this Compound. Recommended administration length is 8-12 weeks. Note: LGD-4033 is for sale on this site for Research Purposes only. By purchasing from this site, you are agreeing to use this compound for Research Purposes.

LGD-4033

LGD-4033 is a novel nonsteroidal, oral Selective Androgen Receptor Modulator that binds to the androgen receptor with high affinity and selectivity.

LIGANDROL

Read More
MK-2866 (Osterine) also known as Enobosarm is an investigational selective androgen receptor modulator (SARM) primarily developed for the treatment of conditions such as muscle wasting and osteoporosis. As such, it makes an ideal candidate compound for your personal Research Projects. This compound has displayed a significant improvement in the general physiology of test subjects, including improved Body Re-composition, fat loss and a marked increase in Lean muscle mass (improving the test subjects Body Mass Index). Physiological improvements of test subjects are considered very dry with no water retention and a substantial improvement in the quality and density of muscle fiber tissue. This compound is not as strong as its common counterpart (LGD-4033) but is drier in nature. The Pro version of MK-2866 contains an "Absorb Core" base to improve bioavailability and to extend the half-life of the compound, making it one of the strongest and most efficient on the Research Compound market. This compound is VERY efficient and more effective in Females test subjects at much lower dosages. Mk-2866 is slightly suppressive so a light PCT is required following administration of a course of this Compound. Recommended administration length is 8-12 weeks. Note: MK2866 is for sale on this site for Research Purposes only. By purchasing from this site, you are agreeing to use this compound for Research Purposes.

MK-2866

MK-2866 (Osterine) also known as Enobosarm is an investigational selective androgen receptor modulator (SARM) primarily developed for the treatment of conditions such as muscle wasting and osteoporosis

OSTARINE

Read More
MK677 is not a Selective Androgen Receptor Modulator. It is a Research Chemical of the secretagogue class. More specifically it is a growth hormone secretagogue. This GHS (Growth Hormone Secretagogue) is an orally active compound that signals for the pituitary gland of test subjects to secrete growth hormone. It was developed with the aim of combating such conditions as muscle wasting, obesity and osteoporosis. This makes it an ideal candidate compound for researchers working on the effects of Grown Hormone levels and associated changes in physiology, muscle mass and changes to body mass index. The administration of MK-677 within test subjects can stimulate significant changes in Muscle Mass and density. MK-677 will also greatly increase the appetite of any test subject. As MK-677 acts as a GHS it is non-suppressive. This means that suitable research projects can extend from a period of 30 days to 1 year. The Pro version of MK-677 contains an "Absorb Core" base to improve bioavailability and to extend the half-life of the compound, making it one of the strongest and most efficient on the Research Compound market. Note: MK-677 is for sale on this site for Research Purposes only. By purchasing from this site, you are agreeing to use this compound for Research Purposes.

MK-677

MK677 is not a Selective Androgen Receptor Modulator. It is a Research Chemical of the secretagogue class.

IBUTAMOREN

Read More
RAD-140 is regarded as the SARM with the closest chemical structure and properties to testosterone. It has an anabolic / androgenic ratio of 90:1. In test subjects it has produced significant effects on muscle tissue size and density. Within the physiology of test subjects the compound cannot aromatize to Estrogen. This makes RAD-140 the ideal candidate compound if your research is based on muscle density and quality. It is a fast-acting compound that brings rapid results to your research, typically being faster acting than most Selective Androgen Receptor Modulators. The anabolic / androgenic ratio of this compound also makes it Anti-Catabolic when the test subject is in a caloric deficit. RAD-140 is ideally suited to research with other SARMS such as MK-2866 and LGD-4033. The Pro version of RAD-140 contains an "Absorb Core" base to improve bioavailability and to extend the half-life of the compound, making it one of the strongest and most efficient on the Research Compound market. RAD-140 is slightly suppressive so a light PCT is required following administration of a course of this Compound. Recommended administration length is 8-12 weeks. Note: RAD-140 is for sale on this site for Research Purposes only. By purchasing from this site, you are agreeing to use this compound for Research Purposes.

RAD-140

RAD-140 is regarded as the SARM with the closest chemical structure and properties to testosterone.

TESTOLONE

Read More
S-23 is a relatively new Selective Androgen Receptor Modulator. It is highly supressive at dosages >50mg per day. Physiological improvements of test subjects are considered dry and demonstrate a substantial improvement in the quality and density of muscle fiber tissue. The Pro version of S-23 contains an "Absorb Core" base to improve bioavailability and to extend the half-life of the compound, making it one of the strongest and most efficient on the Research Compound market. S-23 is highly suppressive so a full PCT is required following administration of a course of this Compound. Recommended administration length is 4-8 weeks. Note: S-23 is for sale on this site for Research Purposes only. By purchasing from this site, you are agreeing to use this compound for Research Purposes.

S-23

S-23 is a relatively new Selective Androgen Receptor Modulator. It is highly supressive at dosages >50mg per day.

S-23 pro

Read More
S-4 (Andarine) is a Selective Androgen Receptor Modulator (SARM) that does not have androgenic activity in non-skeletal-muscle tissues. The physiological effects of S-4 on research subjects includes increased density and hardening of muscle fibre tissue, fat oxidisation and nutrient partitioning. The compound also has a mild effect on Oestrogen levels. This compound was designed for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound. This makes S-4 an ideal candidate compound if your research is based around either muscle tissue hardening, fat oxidisation, bone density or a combination of all three. Physiological improvements of test subjects are considered very dry with zero water retention and a substantial improvement in the density of muscle fibre tissue. The Pro version of S-4 contains an "Absorb Core" base to improve bioavailability and to extend the half-life of the compound, making it one of the strongest and most efficient on the Research Compound market. S-4 is slightly suppressive so a light PCT is required for test subjects following administration of a course of this Compound. Recommended administration length is 8-12 weeks. Note: S-4 is for sale on this site for Research Purposes only. By purchasing from this site, you are agreeing to use this compound for Research Purposes.

S-4

S-4 (Andarine) is a Selective Androgen Receptor Modulator (SARM) that does not have androgenic activity in non-skeletal-muscle tissues.

ANDARINE

Read More
SR-9009 (Stenabolic) is not a true Selective Androgen receptor Modulator. It is a Rev-ErbA ligand. As such, it binds to this protein and makes it more active. This results in physiological changes of test subjects including fat loss, enhanced endurance capability, and increases of size and density of muscle fiber tissue. Because it is an orally active Rev-Erb ligand it is a unique compound. By stimulating the Rev-Erb protein, SR9009 can greatly influence a lot of regulatory mechanisms in the subject’s body. For instance, it can affect the circadian rhythms, lipid and glucose metabolism, fat-storing cells, as well as macrophages. Hence, Stenabolic will result in fat loss and drastically increased endurance of the test subject. By binding and activating the Rev-Erb protein, Stenabolic triggers a very wide range of processes in the body. The most prominent being the increase of mitochondria count in the muscles and an enhanced metabolism. As a consequence of the increased number of mitochondria in the muscles, the test subject will typically notice a drastic increase in muscle strength. In fact, the mice used in studies could run with 50% greater efficiency when they were administered with SR9009 - both in terms of distance and time. This is possible because these mitochondria are precisely the ones generating energy in the body. This change in metabolic rates increases energy expenditure by 5% even when the subject is resting; hence, SR-9009 burns excess calories and doesn 't allow them to convert into fat. This, coupled with enhanced metabolism of glucose, helps effectively convert fat into energy, which makes the body act is if it were in a constant state of exercise. The Pro version of SR-9009 contains an "Absorb Core" base to improve bioavailability and to extend the half-life of the compound, making it one of the strongest and most efficient on the Research Compound market. Recommended administration length is 8-12 weeks. Note: SR-9009 is for sale on this site for Research Purposes only. By purchasing from this site, you are agreeing to use this compound for Research Purposes.

SR-9009

SR-9009 (Stenabolic) is not a true Selective Androgen receptor Modulator. It is a Rev-ErbA ligand. As such, it binds to this protein and makes it more active.

STENABOLIC

Read More
YK-11 is a relatively new compound. It is a Partial Androgen Receptor Agonist (PARA), so it is not a true SARM. Instead, it is often classed as a Myostatin Inhibitor- which is where its real strengths lie. Myostatin is the body’s breaking system for the formation of muscle tissue. If these breaks are removed, then the effects on physiology can be increased. This makes YK-11 one of the most interesting Research Chemicals to come to the market in recent years. It is an ideal compound choice if your research is linked to the effects of Myostatin on other Research Chemicals. YK-11 is great for research on its own, but is a prime candidate for research in conjunction with other Research Chemicals. The Pro version of YK-11 contains an "Absorb Core" base to improve bioavailability and to extend the half-life of the compound, making it one of the strongest and most efficient on the Research Compound market. Recommended administration length is 8-12 weeks. Note: YK11 is for sale on this site for Research Purposes only. By purchasing from this site, you are agreeing to use this compound for Research Purposes.

YK-11

YK-11 is a relatively new compound. It is a Partial Androgen Receptor Agonist (PARA), so it is not a true SARM.

MYOSTINE

Read More
Scientist

Selective Androgen Receptor Modulators(Sarms)

​FOR RESEARCH ONLY

bottom of page